- Lobbying
- Sarah AND Egge
Lobbying Arrangements Results for 'Sarah Egge'
Former Covered Federal Workers:
Other Lobbyists:
Issue | Client | Firm | Lobbyists | Start Date | Latest Filing Date |
---|---|---|---|---|---|
Details Charitable premium assistance and end-stage renal disease issues. |
American Kidney Fund
|
Ernst & Young LLP (Washington Council Ernst & Young) | |||
Details FDA Reauthorization Act - HR 2430;HR 2212/S 974 - CREATES Act; HR 2051 - FAST Generics Act |
Celgene Corporation
|
Ernst & Young LLP (Washington Council Ernst & Young) | |||
Details Extend funding for Community Health. Medicaid reform proposals. H.R. 1628, American Health Care Reform Act and the Senate Better Care Act. |
National Association of Community Health Centers
|
Ernst & Young LLP (Washington Council Ernst & Young) | |||
Details Medicare Advantage, H.R. 246 - HIT repeal, H.R. 1628 - The American Health Care Reform Act and the Senate amendment. Risk-based capital requirements for health insurers |
UnitedHealth Group
|
Ernst & Young LLP (Washington Council Ernst & Young) | |||
Details Exchanges and health insurance issues. HR 2575, Save American Workers Act, ACA definition of full-time employee; S2176, Common Sense Reporting Act, Reporting streamlining under Code sections 6055/6... |
National Association of Health Underwriters (NAHU)
|
Ernst & Young LLP (Washington Council Ernst & Young) | |||
Details Mental health and substance abuse issues, including the Comprehensive Addiction and Recovery Act implementation (P.L. 114-198)and Labor, HHS and Commerce, Justice, Science appropriations bill |
Alkermes, Inc.
|
Ernst & Young LLP (Washington Council Ernst & Young) | |||
Details ACA Employer Reporting and Common Sense Reporting Act (S 1996, HR 2712). |
Retail Industry Leaders Association
Association representing the retail industry |
Ernst & Young LLP (Washington Council Ernst & Young) | |||
Details Implementation of the employer requirements under Patient Protection and Affordable Care Act for the Employers for Flexibility in Health Care Coalition. ACA Employer Reporting and Common Sense Rep... |
Employers for Flexibility in Heath Care Coalition (Informal Coalition)
|
Ernst & Young LLP (Washington Council Ernst & Young) | |||
Details H.R. 1 - Tax reform - proposals related to repatriation |
Johnson & Johnson Services Inc.(Formerly Johnson & Johnson)
|
Ernst & Young LLP (Washington Council Ernst & Young) | |||
Details Delivery system reforms, coverage and cost of health insurance,medical innovation, and other health care issues. |
Bipartisan Policy Center Advocacy Network
|
Ernst & Young LLP (Washington Council Ernst & Young) | |||
Details Implementation of the employer requirements under Patient Protection and Affordable Care Act for the Employers for Flexibility in Health Care Coalition. ACA Employer Reporting and Common Sense Rep... |
American Staffing Association
|
Ernst & Young LLP (Washington Council Ernst & Young) | |||
Details Implementation of the employer requirements under Patient Protection and Affordable Care Act HR 2575, Save American Workers Act, ACA definition of full-time employee; S2176, Common Sense Reporting ... |
Food Marketing Institute
|
Ernst & Young LLP (Washington Council Ernst & Young) | |||
Details Economic development programs; Low-Income Housing Tax Credit; Tax reform. New Markets Tax Credit. |
Local Initiatives Support Corporation (LISC)
|
Ernst & Young LLP (Washington Council Ernst & Young) | |||
Details Continuing telehealth and audio-only access for patients Ensuring access to telehealth services after the Public Health Emergency; Audio-only telehealth services access; Continuing and expanding Al... |
America's Physician Groups
|
SPLITOAK STRATEGIES LLC | |||
Details HR 5376, Build Back Better Act-impact on rare disease research HR 5376, Build Back Better Act-importance of the Orphan Drug Tax Credit for rare diseases |
Acceleron Pharma, Inc
|
SPLITOAK STRATEGIES LLC | |||
Details Misclassification of Drugs, Program Administration and Program Integrity Updates Under the Medicaid Drug Rebate Program Proposed Rule (CMS-2434-P) -- and operational and patient access challenges w... |
Alkermes, Inc.
|
SPLITOAK STRATEGIES LLC | |||
Details Medicare Coverage and Reimbursement for Transformative Therapies |
Celgene Corporation
|
SPLITOAK STRATEGIES LLC | |||
Details Value of prescription drugs Issues related to Medicare Parts B & D Implementation of P.L. 117-169, Inflation Reduction Act of 2022 SUPPORT Act reauthorization (H.R. 4490, and H.R.4531/S.3393, the ... |
Johnson & Johnson Services, Inc.
|
SPLITOAK STRATEGIES LLC | |||
Details H.R. 1361 - Medicare competitive acquisition rates to complex wheelchairs, S. 486 - Protecting Beneficiary Access to Complex Rehab Technology Act, H.R. 750 - Ensuring Access to Quality Complex Reha... |
United Seating & Mobility LLC dba Numotion
|
Ernst & Young LLP (Washington Council Ernst & Young) | |||
Details International tax issues relating to the OECD global minimum tax and U.S. international tax rules |
American Express
|
Ernst & Young LLP (Washington Council Ernst & Young) | |||
Details Differentiate beer from cannabis; general policy regarding the regulation of the alcohol industry |
Anheuser-Busch Companies
|
SPLITOAK STRATEGIES LLC | |||
Details Education regarding opioid use prevention strategy using digital platform. |
iPug US Inc.
|
SPLITOAK STRATEGIES LLC | |||
Details Protect access to Complex Rehabilitation Technology (CRT) through telehealth evaluation and management; Coverage, coding and reimbursement of power standing and seat elevation; addressing supply ch... |
United Seating and Mobility, LLC dba Numotion
|
SPLITOAK STRATEGIES LLC | |||
Details NAPA Reauthorization Act (S. 133/H.R. 619) Alzheimers Accountability and Investment Act (S. 134/H.R. 620) Comprehensive Care for Alzheimers Act (S. 626/H.R. 1637) Elizabeth Dole Home Care Act of 20... |
Alzheimer's Association
|
in-house lobbying | |||
Details Value of prescription drugs and patient access Issues related to Medicare Parts B & D Implementation of P.L. 117-659 (H.R.5376) - Inflation Reduction Act |
Bristol-Myers Squibb
|
SPLITOAK STRATEGIES LLC | |||
Details Extension of Acute Hospital Care at Home waiver program; Discussion draft of Rep. Wenstrup/Rep. Blumenauer, Hospital Inpatient Services Modernization Act |
Advanced Care at Home (ACH) Coalition
|
SPLITOAK STRATEGIES LLC | |||
Details Value of coordination and management in providing high quality, efficient health care coverage |
UnitedHealth Group
|
SPLITOAK STRATEGIES LLC | |||
Details Update to PACE (Program of All-inclusive for the Elderly) regulations, flexibility in meeting federal requirements for transportation benefit and other requirements |
innovAge (Formerly Total Community Options Foundation)
|
Ernst & Young LLP (Washington Council Ernst & Young) | |||
Details Research, education and public health surveillance of kidney disease; Living Donor Protection Act H.R.2923/S.1384 |
American Kidney Fund
|
SPLITOAK STRATEGIES LLC | |||
Details HR 5397 the Joe Fiandra Access to Home Infusion Act, Issues related to patient access to rare disease therapies, HR 2882 Further Consolidated Appropriations Act of 2024, HR 4366 the Consolidated Ap... |
Chiesi USA, Inc.
|
SPLITOAK STRATEGIES LLC | |||
Details Various health care issues; Coordination of benefits; VA third party care. Medicare and Medicaid program integrity issues. Recovery Audit Contractors and program integrity. |
Health Management Systems, Inc.
|
Ernst & Young LLP (Washington Council Ernst & Young) | |||
Details General healthcare issues implementation of Patient Protection and Affordable Care Act. HR 2575 Save American Workers Act, ACA definition of full-time employee; S 2176 (Common Sense Reporting Act)... |
AETNA INC. (Formerly, AETNA LIFE & CASUALTY)
|
Ernst & Young LLP (Washington Council Ernst & Young) | |||
Details Ensuring access to treatments for rare disease; Value of rare disease research and development; FDA process improvements for rare disease; Improving access for patients with orphan diseases; Improv... |
Amryt Pharma
|
SPLITOAK STRATEGIES LLC | |||
Details RNA interference scientific advancements and rare diseases; differentiation of genetically-targeted therapies; S.476/H.R.5547, Maintaining Investments in New Innovation Act; patient access to appro... |
Alnylam Pharmaceuticals, Inc.
|
SPLITOAK STRATEGIES LLC | |||
Details World Trade Organization's global e-Commerce rules |
MetLife Group, Inc.
|
Ernst & Young LLP (Washington Council Ernst & Young) | |||
Details Access to preventative health; HR 5378 The Lower Costs, More Transparency Act to extend funding for Community Health Centers, Teaching Health Centers GME and the National Health Service Corps; Bipa... |
National Association of Community Health Centers
|
SPLITOAK STRATEGIES LLC | |||
Details General health care issues related to behavioral health and integration with primary care and addressing the opioid epidemic (including H.R.4531/S.3393, the Support for Patients and Communities Rea... |
Bipartisan Policy Center Action
|
SPLITOAK STRATEGIES LLC | |||
Details Improve integration of behavioral health and primary care; advance value-based care; address workforce shortages and improve data collection under Graduate Medical Education program; adequate physi... |
American Academy of Family Physicians
|
SPLITOAK STRATEGIES LLC | |||
Details HR 2407/S 2085 The Medicare Multi-Cancer Early Detection Screening Coverage Act; PAMA lab reporting delay included in HR 6363 Further Continuing Appropriations and other Extensions Act Ensuring acc... |
Caris Science Inc
|
SPLITOAK STRATEGIES LLC | |||
Details Runaway production and related tax issues; entertainment industry issues |
Directors Guild of America, Inc.
|
Ernst & Young LLP (Washington Council Ernst & Young) | |||
Details - H.R. 5378, "Lower Costs, More Transparency Act" - ERISA preemption - S. 1869, the Site-based Invoicing and Transparency Enhancement Act ("SITE Act") - H.R. 4509, Transparency in Billing Act - I... |
American Benefits Council obo Alliance to Fight for Health Care
|
Ernst & Young LLP (Washington Council Ernst & Young) | |||
Details - HR 3561, Promoting Access to Treatments and Increasing Extremely Needed Transparency Act of 2023 (the PATIENT Act) - HR 4507, Transparency in Coverage Act - HR 4822, Health Care Price Transparenc... |
Boeing Company
|
Ernst & Young LLP (Washington Council Ernst & Young) | |||
Details Higher education tax issues; H.R. 5376, Build Back Better Act (fiscal year 2022 budget reconciliation bill) |
Association of American Universities
|
Ernst & Young LLP (Washington Council Ernst & Young) | |||
Details - Telehealth issues - Workforce development; veterans' health care; Medicare reimbursement including "incident to" billing; Medicare hospice restrictions; transparency; opioid addiction treatment... |
American Academy of Physician Associates
|
Ernst & Young LLP (Washington Council Ernst & Young) | |||
Details Railroad re-regulation; rail safety; tax reform; highway trust fund. Miscellaneous environmental issues. Railroad regulations and infrastructure development. |
Association of American Railroads
|
Ernst & Young LLP (Washington Council Ernst & Young) | |||
Details Higher education tax issues including: charitable giving; taxation of scholarship grants and Pell / AOTC interaction; enhancing higher education tax credits; repealing the endowment tax; expanding ... |
American Council on Education
|
Ernst & Young LLP (Washington Council Ernst & Young) |